Peter Albers

17PUBLICATIONS
72CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Cancer diagnosisMolecular targetsInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 13, 2026
Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review.

Maxime De Vrieze, Nan Zhang, Petra Seibold

|Dec 11, 2025
Analysis of Operator Expertise in MRI/TRUS Fusion-Guided Prostate Biopsy.

Rouvier Al-Monajjed, Lars Schimmöller, Jale Lakes

|Sep 13, 2025
Modern active surveillance in low- and intermediate-risk prostate cancer without re-biopsy.

Jale Lakes, Rouvier Al-Monajjed, Isabelle Busshoff

|Aug 29, 2024
Prostate Cancer Screening in Young Men.

Maxime De Vrieze, Rouvier Al-Monajjed, Matthias Boschheidgen

|May 24, 2024
Value-Based Health Care for Prostate Cancer Centers by Implementing Specific Key Performance Indicators Using a Balanced Score Card.

Jan Philipp Radtke, Peter Albers, Boris A Hadaschik

|Sep 19, 2023
Characterizing the mutational burden, DNA methylation landscape, and proteome of germ cell tumor-related somatic-type malignancies to identify the tissue-of-origin, mechanisms of therapy resistance, and druggable targets.

Felix Bremmer, Pailin Pongratanakul, Margaretha Skowron

Pageof 3

Frequent Collaborators

4 joint publications

Daniel Nettersheim

3 joint publications

Lars Schimmöller

3 joint publications

Margaretha A Skowron

2 joint publications

Stefan Schönberger